Notably, studies have shown that GSDME knockout impairs the therapeutic efficacy of ceritinib in NCI-H3122 cells, whereas GSDME knockdown attenuates the antitumor effect of cisplatin in oral squamous cell carcinoma (Lu et al., 2018; Wang et al., 2022). Here, GSDME is linked to oral cavity squamous cell carcinoma.